RxDoctor Payments Data

Peter Valora, PA

Physician Assistant · Rexburg, IDNPI 1184097370

Payments from drug & device makers

$1,747in general payments, 2019–2025

Across 99 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$105
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$24
  • Nestle Healthcare Nutrition Inc.$16
  • Biohaven Pharmaceutical Holding Company Ltd.$15
  • Apria Healthcare LLC$14
  • plus $36 from 3 others

What the payments were for

  • Food & beverage$1,73599%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,747 in reported general payments places this provider in the 80th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$23,932
Medicare patients
101
Services billed
1,001

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ZenpepLipase/Protease/Amylase11$39,076
OzempicSemaglutide19$25,514
FarxigaDapagliflozin Propanediol35$24,060
JardianceEmpagliflozin29$21,729
TrulicityDulaglutide17$15,550
EliquisApixaban23$13,960
Soliqua 100-33Insulin Glargine/Lixisenatide19$11,863
Memantine Hcl ErMemantine Hcl19$10,740
Celecoxib45$5,400
Advair HfaFluticasone Propion/Salmeterol11$3,305
Levothyroxine Sodium150$1,706
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine34$1,683
Pregabalin29$1,491
Duloxetine Hcl51$1,341
Gabapentin72$1,323

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$13$24,06035 claims
Lilly USA, LLCTrulicity$105$15,55017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Rexburg

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →